image
Healthcare - Biotechnology - NASDAQ - US
$ 2.27
0 %
$ 229 M
Market Cap
-0.8438661710037175
P/E
Price Target Average
384.58%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
25.99%
Net Income Estimate
12.06%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Acelyrin, Inc.
image
Wall Street analysts predict an average 1-year price target for SLRN of $11 , with forecasts ranging from a low of $6 to a high of $15 .
SLRN Lowest Price Target Wall Street Target
6 USD 164.32%
SLRN Average Price Target Wall Street Target
11 USD 384.58%
SLRN Highest Price Target Wall Street Target
15 USD 560.79%
Price
Max Price Target
Min Price Target
Average Price Target
16161414121210108866442200Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart SLRN

image
$180.0m$180.0m$160.0m$160.0m$140.0m$140.0m$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.0202320232024202420252025202620262027202720282028
EBIT FORECAST

EBIT Forecast Chart SLRN

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)202320232024202420252025202620262027202720282028
NET INCOME FORECAST

Net Income Chart SLRN

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)202320232024202420252025202620262027202720282028